Nalaganje...
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Renal cell carcinoma (RCC) affects > 60,000 people in the United States annually, and ~ 30% of RCC patients have multiple metastases at the time of diagnosis. Metastatic RCC (mRCC) is incurable, with a median survival time of only 18 months. Immune-based interventions (e.g., interferon (IFN) and...
Shranjeno v:
| izdano v: | J Vis Exp |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MyJove Corporation
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564692/ https://ncbi.nlm.nih.gov/pubmed/28448047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3791/55080 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|